在神经退行性疾病中miR-137的作用
László Bodai1, Roberta Borosta1, Ágnes Ferencz1
1Department of Biochemistry and Molecular Biology, Faculty of Science and Informatics, University of Szeged, Közép fasor 52, H-6726 Szeged, Hungary.
International journal of molecular sciences
|July 13, 2024
概括
像miR-137这样的微RNA (miRNA) 在神经退行性疾病中至关重要. 这篇评论显示miR-137独特地影响阿尔茨海默病,帕金森病和其他大脑疾病,而不仅仅是保护它们.
科学领域:
- 神经科学是一个神经科学.
- 分子生物学分子生物学
- 遗传学 遗传学 是一个
背景情况:
- 神经退行性疾病构成了日益严重的全球健康挑战.
- 基因表达失调是神经退行病原发生的一个关键因素.
- 微RNAs (miRNAs) 是基因表达的关键调节者.
研究的目的:
- 审查神经元丰富的微RNA,miR-137在神经退行症中的作用.
- 检查miR-137在阿尔茨海默病,帕金森病,亨廷顿病,肌缩侧面硬化症和多发性硬化症中的参与.
主要方法:
- 关于miR-137和神经退行性疾病现有研究的文献综述.
- 在不同神经病理背景下分析miR-137的功能.
主要成果:
- miR-137与几个主要的神经退行性疾病的发病有关.
- 在所有研究疾病中,miR-137的神经保护作用并不均.
- miR-137可以差异调节不同神经退行性疾病的病理.
结论:
- miR-137在神经退行过程中表现出上下文依赖的作用.
- 针对miR-137可能为不同的神经退行性疾病提供特定的治疗策略.
相关概念视频
MicroRNAs
3.0K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.0K
Neural Regulation
39.3K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.3K
Parkinson's Disease: Overview
522
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
522
Alzheimer's Disease: Overview
461
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
461


